Aeluma director ends 10b5-1 stock sale plan
Aeluma, Inc. reported that director Steven DenBaars has terminated a previously adopted Rule 10b5-1 trading plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Aeluma, Inc. reported that director Steven DenBaars has terminated a previously adopted Rule 10b5-1 trading plan. The plan, adopted on June 23, 2025, had authorized the potential sale of up to 130,000 shares of Aeluma common stock between October 6, 2025 and May 6, 2026 under preset price and formula conditions. On September 16, 2025, the plan was terminated, and the company stated that no sales were or will be made under this 10b5-1 plan.
8-K Event Classification
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Aeluma (ALMU) disclose in this 8-K filing?
Aeluma disclosed that director Steven DenBaars terminated a previously adopted Rule 10b5-1 trading plan and that no stock sales will occur under that plan.
When was the Aeluma (ALMU) director’s 10b5-1 plan adopted and terminated?
The plan was adopted on June 23, 2025 and was terminated on September 16, 2025.
What trading period had been scheduled under the Aeluma (ALMU) 10b5-1 plan?
The plan had scheduled potential sales of Aeluma common stock between October 6, 2025 and May 6, 2026, before it was terminated.
Who is the Aeluma (ALMU) director associated with the terminated 10b5-1 plan?
The Rule 10b5-1 trading plan was adopted and later terminated by director Steven DenBaars.
AI-generated analysis. How Rhea-AI works. Not financial advice.